Founded in 1953 by a visionary Italian chemist, STEROID is today a leading Italian manufacturer of High Potent Active Pharmaceutical Ingredients (HPAPIs) and a globally recognized Contract Development and Manufacturing Organization (CDMO).

With customers in over 30 countries, STEROID partners with top-tier companies in Human Pharma and Animal Health, providing end-to-end support from early development to commercial-scale supply.

Its GMP-compliant facilities, proven regulatory track record with major global health authorities, advanced chemical R&D expertise, and broad range of specialized manufacturing technologies position STEROID as a unique blend of heritage, innovation, flexibility and the excellence of its people. We are committed to continuous growth and technological advancements.

Recent and ongoing investments include:

• HPAPI capabilities up to OEB6 containment

• Gas-liquid and hazardous chemistries including Ammonia, Hydrogen, HF, Methyl Lithium, Ethyl Lithium

• A new GMP Kilolab equipped for cryogenic reactions and chromatographic purification

• A wide array of cutting-edge technologies with flexible batch volumes to meet evolving client needs

With over 70 years of pharmaceutical excellence, every API we manufacture carries a promise: to improve lives with passion, precision, and reliability!

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Substance Manufacturing (API);Research & Development;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

1

High Potent Products capabilities:

OEB >5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);GMP;PMDA (Japan);Health Canada;ANVISA (Brazil)

Current Capacity:

Up to 30 MT available for new businesses.